Eris Lifesciences Closes Trading Window for Insider Trading

Eris Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 01, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. All concerned individuals are advised not to trade in the company's securities during this period. This notice is independent of any other trading window closure announcements.